- Home
- GHRS vs BZH Comparison
GHRS vs BZH Comparison
Compare GHRS & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- BZH
- Stock Information
- Founded
- GHRS 2018
- BZH 1985
- Country
- GHRS Ireland
- BZH United States
- Employees
- GHRS N/A
- BZH N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- BZH Homebuilding
- Sector
- GHRS Health Care
- BZH Consumer Discretionary
- Exchange
- GHRS Nasdaq
- BZH Nasdaq
- Market Cap
- GHRS 774.1M
- BZH 780.6M
- IPO Year
- GHRS 2021
- BZH 1994
- Fundamental
- Price
- GHRS $13.11
- BZH $21.92
- Analyst Decision
- GHRS Strong Buy
- BZH Strong Buy
- Analyst Count
- GHRS 9
- BZH 3
- Target Price
- GHRS $29.33
- BZH $32.00
- AVG Volume (30 Days)
- GHRS 319.1K
- BZH 317.7K
- Earning Date
- GHRS 11-13-2025
- BZH 11-12-2025
- Dividend Yield
- GHRS N/A
- BZH N/A
- EPS Growth
- GHRS N/A
- BZH N/A
- EPS
- GHRS N/A
- BZH 2.23
- Revenue
- GHRS N/A
- BZH $2,385,816,000.00
- Revenue This Year
- GHRS N/A
- BZH N/A
- Revenue Next Year
- GHRS N/A
- BZH $5.53
- P/E Ratio
- GHRS N/A
- BZH $9.82
- Revenue Growth
- GHRS N/A
- BZH 9.97
- 52 Week Low
- GHRS $6.72
- BZH $17.37
- 52 Week High
- GHRS $20.50
- BZH $38.22
- Technical
- Relative Strength Index (RSI)
- GHRS 47.63
- BZH 29.79
- Support Level
- GHRS $12.26
- BZH $24.34
- Resistance Level
- GHRS $13.65
- BZH $25.56
- Average True Range (ATR)
- GHRS 0.75
- BZH 0.73
- MACD
- GHRS -0.08
- BZH -0.32
- Stochastic Oscillator
- GHRS 31.37
- BZH 8.08
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.